Should the COVID Vaccine Turn a Big Profit for Big Pharma?

Powered by RedCircle

In the latest news on the coronavirus, Business Casual hosts Daniel Litwin and Tyler Kern analyze Pfizer CEO Albert Bourla’s recent statement about the ethics behind profiting off of a COVID vaccine.

As the government doles out taxpayer dollars to the private sector in the race for a cure, should the resulting vaccine still come at a price to Americans? Bourla is incredulous at the thought, saying “You need to be very fanatic and radical to say something like that right now.”

Whether private companies are getting aid from the government or not, the private sector has provided diagnostic and therapeutic solutions for COVID already. Business Casual explores both sides of the coin of American capitalism in this unprecedented ethical query, discussing…

  1. How “Operation Warp Speed,” has created costly government contracts with private health companies
  2. Why Pfizer has the potential to make over $13 billion in sales if they charge the public
  3. If the private sector finds a solution to COVID, are they accountable to the public’s taxpayer dollars that helped them create a vaccine?
  4. For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.Follow us on social media for the latest updates in B2B!Twitter – @MarketScale
    Facebook – facebook.com/marketscale
    LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

design
Where Design Meets Durability: Why Commercial Surfaces Must Support Safety, Cleanability, and Long-Term Value
June 8, 2026

When a commercial space fails, it often fails quietly: a lobby floor that becomes slippery when wet, a hotel bathroom that is difficult to clean, a healthcare surface that cannot withstand constant disinfection, or an office finish that looks great until afternoon glare makes the room uncomfortable. These are not purely aesthetic problems; they are…

Read More
creative career
Crafted Journey How To: Building a Creative Career Across Scripts, Stages, and Sound
June 8, 2026

Creative careers rarely move in a straight line, especially for writers working across stage, screen, audio, books, and independent film. Sustaining that kind of life often means finding opportunities wherever they appear, building a strong network, staying open to different formats, and saying yes to collaborations that can lead somewhere unexpected. The stakes are…

Read More
EMR
EMR Strategy, Consulting, and Career Pivots with MedSys Co-Founder Mark Embry
June 8, 2026

Electronic medical records (EMRs) have moved from a back-office upgrade to a frontline determinant of care quality, clinician burnout, and hospital economics. With U.S. hospitals often spending tens to hundreds of millions—sometimes exceeding $100 million—on EMR implementations, the stakes have never been higher for getting both the technology and the human adoption right. As…

Read More
radiology
Growing Without Compromise: How Vision Radiology Balances Scale, AI, and Clinical Quality
June 4, 2026

Radiology sits at the center of a modern healthcare squeeze: imaging volumes are climbing, hospitals need faster reads, and there simply are not enough radiologists to meet demand the old way. At the same time, remote work and AI are reshaping what a clinical practice can look like. The challenge is no longer whether…

Read More